慢乙肝患者-话题@MedSci

#慢乙肝患者#

17篇内容 | 690人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2032512, encodeId=ddf320325123e, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=FIB-4指数：可预测慢乙肝患者抗病毒治疗后的肝癌风险, objectType=article, longId=209889, objectId=5a2f2098893d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a2f2098893d, replyNumber=0, likeNumber=63, createdTime=2021-05-23, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a2f2098893d, moduleTitle=FIB-4指数：可预测慢乙肝患者抗病毒治疗后的肝癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a2f2098893d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032511, encodeId=4eb920325111f, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低, objectType=article, longId=140814, objectId=73b414081494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b414081494, replyNumber=0, likeNumber=59, createdTime=2018-11-15, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b414081494, moduleTitle=J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73b414081494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032508, encodeId=41fb203250828, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Clin Gastroenterol Hepatol：慢乙肝患者的严重肝脂肪变与严重肝纤维化有关, objectType=article, longId=115382, objectId=0ecd115382c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ecd115382c0, replyNumber=0, likeNumber=61, createdTime=2018-04-19, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ecd115382c0, moduleTitle=Clin Gastroenterol Hepatol：慢乙肝患者的严重肝脂肪变与严重肝纤维化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ecd115382c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032506, encodeId=d5e32032506de, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Scand J Gastroenterol：慢乙肝患者肝硬化分期与抗病毒治疗期间发生肝癌的风险, objectType=article, longId=103648, objectId=172710364852, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=172710364852, replyNumber=0, likeNumber=60, createdTime=2018-05-13, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=172710364852, moduleTitle=Scand J Gastroenterol：慢乙肝患者肝硬化分期与抗病毒治疗期间发生肝癌的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=172710364852)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032510, encodeId=5266203251047, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=J Infect Dis：慢乙肝患者替诺福韦或恩替卡韦停药复发的预测因素, objectType=article, longId=126198, objectId=12941261980e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12941261980e, replyNumber=0, likeNumber=0, createdTime=2018-10-19, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12941261980e, moduleTitle=J Infect Dis：慢乙肝患者替诺福韦或恩替卡韦停药复发的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12941261980e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032509, encodeId=3c00203250956, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Clin Transl Gastroenterol：慢乙肝患者应用恩替卡韦治疗7年的转归结果, objectType=article, longId=119956, objectId=3b4611995631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b4611995631, replyNumber=0, likeNumber=46, createdTime=2018-01-22, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b4611995631, moduleTitle=Clin Transl Gastroenterol：慢乙肝患者应用恩替卡韦治疗7年的转归结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b4611995631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032507, encodeId=9ad0203250e51, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, objectType=article, longId=106882, objectId=61e910688226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61e910688226, replyNumber=0, likeNumber=59, createdTime=2017-09-16, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61e910688226, moduleTitle=J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61e910688226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032505, encodeId=a77a2032505e2, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=慢乙肝患者停药将有检验依据, objectType=article, longId=92496, objectId=af4392496c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4392496c3, replyNumber=0, likeNumber=46, createdTime=2017-11-15, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4392496c3, moduleTitle=慢乙肝患者停药将有检验依据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4392496c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032504, encodeId=ae022032504a3, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好, objectType=article, longId=70400, objectId=e9bae04003f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9bae04003f, replyNumber=0, likeNumber=50, createdTime=2016-08-31, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9bae04003f, moduleTitle=PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9bae04003f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032503, encodeId=399520325036c, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Gut：口服抗病毒药物治疗慢乙肝患者较非活动性肝炎患者发展为肝癌的风险更大, objectType=article, longId=44856, objectId=c75044856f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75044856f3, replyNumber=0, likeNumber=48, createdTime=2015-03-10, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75044856f3, moduleTitle=Gut：口服抗病毒药物治疗慢乙肝患者较非活动性肝炎患者发展为肝癌的风险更大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75044856f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032501, encodeId=aa402032501d9, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=APT：ALT正常的慢乙肝患者肝纤维化比例仍较高, objectType=article, longId=31149, objectId=a23831149ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a23831149ec, replyNumber=0, likeNumber=41, createdTime=2014-12-27, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a23831149ec, moduleTitle=APT：ALT正常的慢乙肝患者肝纤维化比例仍较高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a23831149ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032502, encodeId=b45d20325023c, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=J Hepatol：慢乙肝患者发生了自发性HBsAg清除后，还需要进行HCC监测吗？, objectType=article, longId=44855, objectId=c021448557a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c021448557a, replyNumber=0, likeNumber=43, createdTime=2015-11-28, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c021448557a, moduleTitle=J Hepatol：慢乙肝患者发生了自发性HBsAg清除后，还需要进行HCC监测吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c021448557a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032500, encodeId=57b02032500bc, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Gut：Besifovir或可成为慢乙肝患者治疗新选择, objectType=article, longId=28745, objectId=b67828e451c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b67828e451c, replyNumber=0, likeNumber=41, createdTime=2014-01-21, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b67828e451c, moduleTitle=Gut：Besifovir或可成为慢乙肝患者治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b67828e451c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032498, encodeId=e5b720324985d, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=J Hepatol：LSM-HCC评分可准确预测慢乙肝患者肝癌发生风险, objectType=article, longId=25617, objectId=36472561e7d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36472561e7d, replyNumber=0, likeNumber=43, createdTime=2014-03-07, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36472561e7d, moduleTitle=J Hepatol：LSM-HCC评分可准确预测慢乙肝患者肝癌发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36472561e7d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032499, encodeId=1bd82032499d2, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Hepatology：香港中文大学Vincent WS Wong等发现AFP为诊断恩替卡韦治疗慢乙肝患者发生肝癌的特异性肿瘤标记物, objectType=article, longId=26581, objectId=4fb426581aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fb426581aa, replyNumber=0, likeNumber=49, createdTime=2014-10-04, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fb426581aa, moduleTitle=Hepatology：香港中文大学Vincent WS Wong等发现AFP为诊断恩替卡韦治疗慢乙肝患者发生肝癌的特异性肿瘤标记物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fb426581aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032497, encodeId=f645203249ed7, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准, objectType=article, longId=21388, objectId=c01b2138812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01b2138812, replyNumber=0, likeNumber=41, createdTime=2014-01-04, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01b2138812, moduleTitle=Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c01b2138812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032496, encodeId=62332032496a6, content=<a href='/topic/show?id=1401534265f' target=_blank style='color:#2F92EE;'>#慢乙肝患者#</a>, objectTitle=恩替卡韦部分应答及耐药慢乙肝患者联合ADV治疗1例, objectType=article, longId=21378, objectId=f746213e822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f746213e822, replyNumber=0, likeNumber=46, createdTime=2014-04-16, rootId=0, userName=wincls, userId=991e83, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f746213e822, moduleTitle=恩替卡韦部分应答及耐药慢乙肝患者联合ADV治疗1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f746213e822)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢乙肝患者

2020-05-29

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

FIB-4指数：可预测慢乙肝患者抗病毒治疗后的肝癌风险

2021-05-23

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低

2018-11-15

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Clin Gastroenterol Hepatol：慢乙肝患者的严重肝脂肪变与严重肝纤维化有关

2018-04-19

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Scand J Gastroenterol：慢乙肝患者肝硬化分期与抗病毒治疗期间发生肝癌的风险

2018-05-13

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

J Infect Dis：慢乙肝患者替诺福韦或恩替卡韦停药复发的预测因素

2018-10-19

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Clin Transl Gastroenterol：慢乙肝患者应用恩替卡韦治疗7年的转归结果

2018-01-22

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

J Hepatol：在使用富马酸替诺福韦二吡呋酯（TDF）取得长期病毒学应答的非肝硬化的e抗原阴性的慢乙肝患者中停药的研究——FINITE研究

2017-09-16

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

慢乙肝患者停药将有检验依据

2017-11-15

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

PLOS ONE：NAPs 用于HBeAg阳性慢乙肝患者效果良好

2016-08-31

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Gut：口服抗病毒药物治疗慢乙肝患者较非活动性肝炎患者发展为肝癌的风险更大

2015-03-10

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

APT：ALT正常的慢乙肝患者肝纤维化比例仍较高

2014-12-27

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

J Hepatol：慢乙肝患者发生了自发性HBsAg清除后，还需要进行HCC监测吗？

2015-11-28

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Gut：Besifovir或可成为慢乙肝患者治疗新选择

2014-01-21

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

J Hepatol：LSM-HCC评分可准确预测慢乙肝患者肝癌发生风险

2014-03-07

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Hepatology：香港中文大学Vincent WS Wong等发现AFP为诊断恩替卡韦治疗慢乙肝患者发生肝癌的特异性肿瘤标记物

2014-10-04

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

Hepatology：HBeAg阴性慢乙肝患者应用ETV停药标准

2014-01-04

wincls (审核中...)

前往app查看评论内容

#慢乙肝患者#

恩替卡韦部分应答及耐药慢乙肝患者联合ADV治疗1例

2014-04-16

科室
- - 订阅+
  - 更多科室
工具
服务